(Q37106028)

18 August 2017

1 reference

title

Mechanisms of drug resistance in status epilepticus (English)

1 reference

18 August 2017

1 reference

Wolfgang Löscher

1

1 reference

18 August 2017

publication date

1 January 2007

1 reference

18 August 2017

1 reference

18 August 2017

volume

48 Suppl 8

1 reference

18 August 2017

page(s)

74-77

1 reference

N-methyl-D-aspartate receptor blockade after status epilepticus protects against limbic brain damage but not against epilepsy in the kainate model of temporal lobe epilepsy

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01357.X

Treatment with valproate after status epilepticus: effect on neuronal damage, epileptogenesis, and behavioral alterations in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01357.X

Status epilepticus: pathophysiology and management in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01357.X

Calcium-channel blocker verapamil administration in prolonged and refractory status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01357.X

Characterization of pharmacoresistance to benzodiazepines in the rat Li-pilocarpine model of status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01357.X

Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01357.X

Drug resistance in brain diseases and the role of drug efflux transporters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01357.X

Experimental and clinical evidence for loss of effect (tolerance) during prolonged treatment with antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01357.X

Time-dependent decrease in the effectiveness of antiepileptic drugs during the course of self-sustaining status epilepticus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01357.X

Trafficking of GABA(A) receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01357.X

The neurobiology of antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01357.X

Widespread upregulation of drug-resistance proteins in fatal human status epilepticus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01357.X

10.1111/J.1528-1167.2007.01357.X

21 January 2018

Identifiers

DOI

1 reference

18 August 2017

1 reference